If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvon Protection Regulatory News (AVON)

Share Price Information for Avon Protection (AVON)

Share Price is delayed by 15 minutes
Get Live Data
1,784.00    -12.00 (-0.67%)
Bid:
1,786.00
Ask:
1,800.00
Spread: 14.00 (0.784%)
Market Cap: £525.42m
AVON Live PriceLast checked at - London Stock Exchange

Intraday Avon Protection Share Chart

CEO Succession Update

30 Sep 2022 07:00

RNS Number : 2478B
Avon Protection PLC
30 September 2022
 

30 September 2022

Avon Protection plc

("Avon Protection" or "the Group")

CEO succession update

As set out in the announcement on 24 May 2022, Paul McDonald today steps down from his role as Chief Executive Officer (CEO). The Board is well advanced in the recruitment process for his successor, led by the Nomination Committee with the support of external consultants. In order to ensure executive continuity whilst this selection process is concluded, Bruce Thompson, currently Non-Executive Chair, will become Executive Chair, with effect from 1 October until a new CEO is in place. As a result of this change, Bruce will step down from his role on the Remuneration Committee during this period.

Bruce joined Avon Protection as Non-Executive Chair Designate in March 2020, having previously been Chief Executive Officer of Diploma PLC, the FTSE 250 specialised technical products and services business, for over twenty years.

The Board will make a further announcement regarding the appointment of a new CEO in due course.

For further enquiries, please contact:

Avon Protection

 

Bruce Thompson, Executive Chairman

+44 1225 896 848

Rich Cashin, Chief Financial Officer

 

Rory Wiltshire, Investor Relations Manager

 

 

MHP Communications

 

Andrew Jaques

+44 771 003 2657

Charlie Barker

avonprotection@mhpc.com

Pete Lambie

 

 

Note to editors:

Avon Protection designs and produces life-critical personal protection solutions for the world's militaries and first responders. With a portfolio that includes Chemical, Biological, Radiological, Nuclear ("CBRN"), respiratory and head protection products, our mission is to enhance the performance, efficiency and capability of our customers whilst providing ever increasing levels of protection.

Avon Protection operates from six sites employing approximately 1,000 people and is listed on the London Stock Exchange (LSE: AVON).

For further information, please visit our website www.avon-protection-plc.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOALLMRTMTTTBFT
Date   Source Headline
2nd Dec 20142:31 pmRNSDirector/PDMR Shareholding
2nd Dec 20142:31 pmRNSDirector/PDMR Shareholding
1st Dec 20149:52 amRNSDirector/PDMR Shareholding
19th Nov 20147:00 amRNSFinal Results
12th Nov 20145:47 pmRNSHolding(s) in Company
6th Nov 20142:21 pmRNSDirector/PDMR Shareholding
8th Oct 20144:06 pmRNSDirector/PDMR Shareholding
3rd Oct 20147:00 amRNSPre close trading update
16th Sep 20146:08 pmRNSHolding(s) in Company
8th Sep 201412:29 pmRNSDirector/PDMR Shareholding
7th Aug 20145:56 pmRNSDirector/PDMR Shareholding
6th Aug 20147:00 amRNSInterim Management Statement
14th Jul 20142:38 pmRNSHolding(s) in Company
9th Jul 20149:30 amRNSDirector/PDMR Shareholding
16th Jun 20145:03 pmRNSHolding(s) in Company
6th Jun 201412:33 pmRNSDirector/PDMR Shareholding
6th Jun 20147:00 amRNSUS $33m order for US DOD
7th May 20144:01 pmRNSDirector/PDMR Shareholding
7th May 20148:47 amRNSHolding(s) in Company
30th Apr 20147:00 amRNSHalf Yearly Report
15th Apr 20141:46 pmRNSHolding(s) in Company
8th Apr 20149:58 amRNSDirector/PDMR Shareholding
1st Apr 20149:13 amRNSHolding(s) in Company
28th Mar 20147:01 amRNSPre close trading update
10th Mar 201412:27 pmRNSHolding(s) in Company
6th Mar 20149:38 amRNSDirector/PDMR Shareholding
6th Mar 20147:00 amRNSUS facility consolidation
17th Feb 20144:58 pmRNSHolding(s) in Company
13th Feb 20145:21 pmRNSHolding(s) in Company
7th Feb 201411:39 amRNSDirector/PDMR Shareholding
6th Feb 20142:10 pmRNSResult of AGM
6th Feb 20147:00 amRNSInterim Management Statement
27th Jan 20148:51 amRNSHolding(s) in Company
14th Jan 20144:30 pmRNSHolding(s) in Company
14th Jan 20144:02 pmRNSDirector/PDMR Shareholding
9th Jan 201411:25 amRNSHolding(s) in Company
7th Jan 20145:14 pmRNSDirector/PDMR Shareholding
30th Dec 20137:00 amRNSHolding(s) in Company
30th Dec 20137:00 amRNSHolding(s) in Company
16th Dec 20139:35 amRNSHolding(s) in Company
11th Dec 201312:44 pmRNSAnnual Financial Report
5th Dec 20134:34 pmRNSDirector/PDMR Shareholding
5th Dec 20133:51 pmRNSDirector/PDMR Shareholding
29th Nov 20133:02 pmRNSDirector/PDMR Shareholding
29th Nov 201311:29 amRNSTotal Voting Rights
25th Nov 201311:15 amRNSIssue of Equity
21st Nov 20132:41 pmRNSDirector/PDMR Shareholding
20th Nov 20137:00 amRNSFinal Results
6th Nov 20134:50 pmRNSDirector/PDMR Shareholding
30th Oct 20133:17 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.